Market Summary

The global Hemostats market size was valued at USD 2.95 billion in 2025 and is projected to reach USD 6.15 billion by 2033, growing at a CAGR of 9.30% from 2026 to 2033. The market is recording a steady CAGR growth on the basis of growing volumes, rising prevalence of chronic disorders, and the increasing demand for advanced bleeding control solutions. Other factors that reinforce the growth over a longer period of time include technological improvements, expanding minimally invasive procedures, and higher adoptions across outpatient settings.

Market Size & Forecast

• 2025 Market Size: USD 2.95 Billion
• 2033 Projected Market Size: USD 6.15 Billion
• CAGR (2026-2033): 9.30%
• North America: Largest Market in 2026
• Asia Pacific: Fastest Growing Market

To learn more about this report,  Download Free Sample Report

Key Market Trends Analysis

• North America is expected to retain a large presence, primarily because of the large number of global surgeries performed, acceptance of advanced hemostatic technology, as well as comprehensive reimbursement support. A rising preference for minimal procedures is also accelerating adoption.
• The US dominates regional market growth, driven by strong clinical awareness, high trauma and cardiovascular surgeries, and innovations in products. Large-scale manufacturers and efficient approvals processes ensure rapid launches of innovative hemostatic solutions in the market
• The Asia Pacific is the fastest-growing geography due to the rise in healthcare infrastructure development, advancing surgical awareness, and investments in the hospitals segment. An increase in the number of elective surgeries and the accessibility of sophisticated surgery products further boosts the demand.
• Combination hemostats are emerging as popular product types because of their effectiveness and usage in various surgical procedures. They are becoming more and more sought after in a variety of high-risk operations due to their ability to handle unpredictable bleeding.
• Matrix and gel-based hemostats are turning out to be the most prominently adopted forms and their adaptability and ease of use are mainly contributing to their requirement and demand. Their increasing demand in minimally invasive surgeries and laparoscopy is creating strong segment growth.
• However, orthopedic surgery continues to be the dominant market, driven by rising joint replacement and trauma procedures. The high level of blood loss during orthopedic surgery is a market driver for sophisticated and rapid-acting hemostasis products.
• Hospitals and clinics have continued to be the leading market by end use, driven by high volumes of procedures and availability of advanced surgery technology. This market has also been supported by central purchasing and the availability of skilled surgeons.

So, The market for hemostats includes a variety of medical devices used to stop bleeding during traumatic and surgical procedures. In a variety of clinical purposes, products in this category aid in improving surgical efficiency, lowering blood loss, and minimizing postoperative problems. Hemostats are widely used in emergency care settings, ambulatory surgery clinics, and hospitals. Market growth is very much linked to the growing numbers of surgical procedures being performed worldwide, owing to the increasing aging population, the rise in the numbers of people affected with chronic diseases, and growing accessibility to healthcare. Improvements in surgical methods, especially those involving minimally invasive and laparoscopic surgeries, have further fueled demand for simpler and rapid-acting hemostats. Moreover, at the same time, rising knowledge about patient safety issues and demands to compress operation time as well as transfusion risk have increased adoption trends in developed as well as emerging markets. Also, government approvals as well as increased knowledge about advanced hemostatic products have been critical factors facilitating continuous growth of the marketplace. All these factors make it possible for the marketplace to witness steady growth.

Hemostats Market Segmentation

By Type

• Thrombin-Based Hemostats

These agents act directly upon the clotting mechanism and, as a result, are extremely efficient in the control of bleeding. Their rapid onset and efficacy ensure considerable use of these agents during complex and high-risk operations.

• Oxidized Regenerated Cellulose (ORC)

ORC based hemostats are widely favored due to their absorbability and biocompatibility. These hemostats are used in general surgeries where mild as well as moderate bleeding needs to be controlled.

• Combination Hemostats

Combination hemostats provide a combination of mechanical support and active clotting agents, thereby providing a wider range of efficacy. They can be used for surgical procedures that involve unpredictable bleeding sites.

• Others

This section covers products that are either collagen-based or chitosan-based. These products are used in niche markets. Demand is driven by innovation as well as increased usage of these products in emergency care.

To learn more about this report,  Download Free Sample Report

By Formulation

• Matrix & Gel Hemostats

These are better suited to irregular surfaces around the wound and are favored by surgeons in the case of minimally invasive and laparoscopic surgeries because of the ease of application.

• Sponge Hemostats

Sponge products work mechanically, adhering and absorbing the blood effectively. This practicality and economy have made the sponge the mainstay in conventional surgical procedures.

• Powder Hemostats

Powder formulations are also finding popularity due to their fast dispersion properties and ability to cover extensively bleeding sites. They are especially useful in trauma and emergency surgical procedures.

• Others

Other products, such as films and patches, satisfy various procedural demands. Steady adoption is being witnessed due to increased focus on tailored surgery solutions.

By Application

• Orthopedic Surgery

Advanced hemostats are in high demand due to the high blood loss associated with bone and joint procedures. The segment benefits from rising orthopedic surgeries linked to aging populations.

• General Surgery

General surgery is a procedure type that serves as a consistent demand base because of the high volume executed in every part of the world. Hemostats herein are valued for their reliability, safety, and ease of use.

• Neurosurgery

Precision and safety are paramount during neurological procedures, suggesting the employments of advanced hemostatic solutions. Even minor control of bleeding has a significant consequence on surgical outcomes.

• Cardiovascular Surgery

Cardiovascular procedures include complex vascular structures that raise the need for speedy and efficacious hemostasis. High-risk profiles make advanced products highly essential in this segment.

• Others

This includes dental, gynecological, and cosmetic surgeries where controlled bleeding improves recovery. Growth is supported by rising outpatient and elective procedures.

By End Use

• Hospitals & Clinics

Hospitals are the major users because of the high number of surgeries and the availability of sophisticated surgery equipment. Buying power enables the preference of high-quality hemostatic products.

• Ambulatory Surgical Centers (ASC)

The ASCs are experiencing an increasing adoption rate because of the trend towards minimal and outpatient surgeries. Cost-effectiveness and quick recovery solutions are driving the demand in this context.

• Casualty Care Centers

For emergency and trauma centers, the need is for quick-acting hemostats. With the rise in the number of accidents and traumas happening worldwide, the importance of this type of segment is increased.

• Others

The market segment comprises military treatment facilities, field treatment, and specialty clinics. The driving factors are portability, simplicity of use, and functionality in non-traditional environments.

Regional Insights

North America is comprises the US, Canada and Mexico, currently dominates the global market because of its sophisticated medical infrastructure and high surgical volume rates, as well as the willingness to adopt innovative technologies in medicine. Currently, the US leads the pack as the major contributor to the global market because of its favorable fee structures and the relative high awareness levels among surgeons. Europe, including Germany, the UK, France, Spain, Italy, and the remaining part of Europe, is experiencing positive growth due to aging populations that are increasingly resorting to elective procedures. Europe maintains stringent regulations that ensure patient safety hence, there is focus on using quality hemostatic products.

Asia Pacific comprising Japan, China, Australia & New Zealand, South Korea, India, and others is the most rapidly growing market. The increased development of healthcare infrastructure, the surge in medical tourism, and greater accessibility to surgical facilities drive markets. South America led by Brazil and Argentina presents a moderate growth, backed by improving healthcare access and increasing surgical awareness. Cost-effective solutions have a higher adoption across both public and private healthcare facilities.

The Middle East & Africa, including countries such as Saudi Arabia, United Arab Emirates, South Africa, and the rest of the region, recorded gradual growth. Long-term market growth was supported by government-led healthcare investments and growing trauma care needs.

To learn more about this report,  Download Free Sample Report

Recent Development News

• May 2025, Merit Medical Systems has completed its acquisition of the hemostatic device manufacturer Biolife Delaware, Inc. for approximately $120 million in cash. The buyout includes StatSeal and WoundSeal devices to cease bleeding. Merit projects the deal will contribute roughly $18 million in revenue next year. Acquiring Biolife adds to a streak of the deals by Merit that includes the $210 million acquisition of Cook Medical's lead management portfolio and $105 million purchase of an acid reflux device from Endogastric Solutions.

(Source:https://www.medtechdive.com/news/merit-buys-hemostatic-device-maker-biolife-for-120m/748681/

• In September 2024, Medcura, Inc., a pioneer in the development of novel hemostasis solutions based on the use of patented biopolymer technology to manage surgically related bleeding, is honored to receive a ‘2024/2025 Best Technology in Spine Award’ for its product, LifeGel Absorbable Hemostatic Gel.

(Source:https://www.prnewswire.com/news-releases/medcuras-hemostatic-agent-lifegel-wins-2024-spine-technology-award-302257962.html?

Key Hemostats Company Insights

Johnson and Johnson is one of the leaders in the hemostats market. This is due to the strong portfolio of advanced hemostatic agents such as Surgicel and ETHIZIA, which is the latest adjunctive solution from the Ethicon division of the company. Its strong distribution channels cover the entire globe, including the Asia Pacific, Europe, and North America regions. Its constant spending on research and development, as well as the acquisition of other companies, helps the company to be strong and meet the tough challenges associated with surgical bleedings. Its leadership is based on the Availability of its products, approvals, and engagement with the healthcare systems.

Key Hemostats Companies:

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc.
• Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Medtronic plc
• Teleflex Incorporated
• Integra LifeSciences Corporation
• Z-Medica LLC
• Advanced Medical Solutions Group plc
• Gelita Medical GmbH
• Artivion, Inc.
• CSL Behring
• Vascular Solutions
• Marine Polymer Technologies, Inc.

Global Hemostats Market Report Segmentation

By Type

• Thrombin Based Hemostats
• Oxidized Regenerated Cellulose Based Hemostats
• Combination Hemostats
• Others

By Formulation

• Matrix & Gel Hemostats
• Sponge Hemostats
• Powder Hemostats
• Others

By Application

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Others

By End Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Casualty Care Centers
• Others

Regional Outlook

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • Australia & New Zealand
  • South Korea
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of the Middle East & Africa